Larazotide
Larazotide acetate · AT-1001 · INN-202
An orally administered peptide studied as a regulator of tight junctions in the intestinal epithelium, investigated in trials for celiac disease alongside a gluten-free diet. Reported to act locally in the gut with minimal systemic absorption.
Tracking and educational reference only, on values you enter yourself. Not medical advice or a dosing recommendation.
Half-life
Acts locally in the gut; a systemic half-life is not well defined. Half-life is an educational pharmacology figure, drawn from public sources, and is not a schedule or dosing instruction.
Storage & handling
Investigational; no approved label defines handling.
References
- PubChem compound record
- Am J Physiol Gastrointest Liver Physiol 2021: pharmacological review of larazotide acetate
- Clin Res Hepatol Gastroenterol 2022: systematic review and meta-analysis in celiac disease
Read the source
Related in Healing / Recovery
Educational reference only, compiled from public sources. Not medical advice, diagnosis, treatment, or a dosing recommendation, and not a recommendation to use any compound. Many compounds listed are research materials not approved for human use. Consult a qualified professional.